• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃塞俄比亚西北部费莱格-希沃特综合专科医院接受治疗的HIV阳性成年患者病毒载量和药物依从性的预测因素

Predictors of Viral Load and Medication Adherence Among HIV-Positive Adults Under Treatment at Felege-Hiwot Comprehensive Specialized Hospital, North-West, Ethiopia.

作者信息

Hussen Tale Abay, Tegegne Awoke Seyoum, Belay Denekew Bitew

机构信息

Department of Statistics, Assosa University, Assosa, Ethiopia.

Department of Statistics, Bahir Dar University, Bahir Dar, Ethiopia.

出版信息

HIV AIDS (Auckl). 2023 Aug 11;15:477-489. doi: 10.2147/HIV.S422980. eCollection 2023.

DOI:10.2147/HIV.S422980
PMID:37593198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10427758/
Abstract

BACKGROUND

Maintaining good medication adherence and decreasing viral load in patients living with HIV/AIDS are critical to ensuring antiretroviral therapy's preventive and therapeutic benefits. The main objective of this study was to assess the predictors of viral load and medication adherence among HIV-positive adults under treatment at Felege Hiwot Comprehensive Specialized Hospital (FHCSH).

METHODS

A retrospective cohort study design was conducted from a random sample of 281 adult HIV-infected patients under treatment at FHCSH in northwest Ethiopia from June 2017 to June 2021. Separate GLMM was used in analysis of viral load and medication adherence, and joint mode was applied to fit those two outcomes jointly. The potential correlation of those two outcomes was linked by random intercepts. Information criteria (AIC and BIC) were used for model comparison and covariance structure selection.

RESULTS

The small standard error of significant predictors and significant correlation between viral load and medication adherence over time provide evidence for joint model selection. The correlation between viral load and medication adherence was -0.7688 (-value=< 0.05), which indicates that the decrement of viral load tends to increase good medication adherence. Patient substance use, visit time, baseline CD4 cell, baseline hemoglobin, and the interaction of visit time by substance use were significantly associated with viral load and medication adherence jointly.

CONCLUSION

The study revealed that substance user adult patients, patients with low baseline CD4 cells, and patients with low baseline hemoglobin were with high viral loads and poor medication adherence. Therefore, health officials and other concerned bodies should give special attention and high intervention to patients with low baseline hemoglobin; poor adherence and low baseline CD4 cell count.

摘要

背景

对于感染艾滋病毒/艾滋病的患者而言,维持良好的药物依从性并降低病毒载量对于确保抗逆转录病毒疗法的预防和治疗效果至关重要。本研究的主要目的是评估在费莱格·希沃特综合专科医院(FHCSH)接受治疗的HIV阳性成年患者中病毒载量和药物依从性的预测因素。

方法

采用回顾性队列研究设计,从2017年6月至2021年6月在埃塞俄比亚西北部FHCSH接受治疗的281名成年HIV感染患者的随机样本中选取。分别使用广义线性混合模型(GLMM)分析病毒载量和药物依从性,并应用联合模型来共同拟合这两个结果。这两个结果的潜在相关性通过随机截距联系起来。信息准则(AIC和BIC)用于模型比较和协方差结构选择。

结果

显著预测因素的小标准误差以及病毒载量和药物依从性随时间的显著相关性为联合模型选择提供了证据。病毒载量与药物依从性之间的相关性为-0.7688(P值<0.05),这表明病毒载量的降低往往会提高良好的药物依从性。患者的物质使用情况、就诊时间、基线CD4细胞、基线血红蛋白以及就诊时间与物质使用的相互作用与病毒载量和药物依从性均显著相关。

结论

该研究表明,有物质使用问题的成年患者、基线CD4细胞低的患者以及基线血红蛋白低的患者病毒载量高且药物依从性差。因此,卫生官员和其他相关机构应特别关注并对基线血红蛋白低、依从性差和基线CD4细胞计数低的患者进行高度干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/326e/10427758/31b8d55da8e9/HIV-15-477-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/326e/10427758/94f5b8ae5c88/HIV-15-477-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/326e/10427758/31b8d55da8e9/HIV-15-477-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/326e/10427758/94f5b8ae5c88/HIV-15-477-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/326e/10427758/31b8d55da8e9/HIV-15-477-g0002.jpg

相似文献

1
Predictors of Viral Load and Medication Adherence Among HIV-Positive Adults Under Treatment at Felege-Hiwot Comprehensive Specialized Hospital, North-West, Ethiopia.埃塞俄比亚西北部费莱格-希沃特综合专科医院接受治疗的HIV阳性成年患者病毒载量和药物依从性的预测因素
HIV AIDS (Auckl). 2023 Aug 11;15:477-489. doi: 10.2147/HIV.S422980. eCollection 2023.
2
Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).埃塞俄比亚西北部(阿姆哈拉地区)费莱格·希沃特教学与专科医院联合纵向数据分析:检测CD4细胞计数变化的决定因素及高效抗逆转录病毒疗法的依从性
AIDS Res Ther. 2017 Mar 16;14(1):14. doi: 10.1186/s12981-017-0141-3.
3
Joint Modeling in Detecting Predictors of CD4 Cell Count and Status of Tuberculosis Among People Living with HIV/AIDS Under HAART at Felege Hiwot Teaching and Specialized Hospital, North-West Ethiopia.埃塞俄比亚西北部费莱格·希沃特教学与专科医院接受高效抗逆转录病毒治疗的艾滋病毒/艾滋病感染者中,联合建模检测CD4细胞计数预测因素及结核病状况
HIV AIDS (Auckl). 2021 May 18;13:527-537. doi: 10.2147/HIV.S307069. eCollection 2021.
4
A Comparison of Adherence and CD4 Cell Count with Respect to Virologic Failure Among HIV-Infected Adults Under Combination Antiretroviral Therapy (cART) at Felege Hiwot Teaching and Specialized Hospital, Bahir Dar, Ethiopia.埃塞俄比亚巴赫达尔市费莱格希沃特教学与专科医院接受联合抗逆转录病毒疗法(cART)的HIV感染成人中,依从性和CD4细胞计数与病毒学失败的比较
HIV AIDS (Auckl). 2022 Feb 2;14:33-44. doi: 10.2147/HIV.S346358. eCollection 2022.
5
Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study.影响埃塞俄比亚西北部费莱格胡托教学和专科医院 HIV 阳性成年人接受抗逆转录病毒治疗第一个月坚持率的因素:一项前瞻性研究。
BMC Infect Dis. 2018 Feb 20;18(1):83. doi: 10.1186/s12879-018-2977-0.
6
Determinants of CD4 cell count change and time-to default from HAART; a comparison of separate and joint models.抗逆转录病毒治疗(HAART)后 CD4 细胞计数变化和发生失效时间的决定因素:单独和联合模型的比较。
BMC Infect Dis. 2018 Apr 27;18(1):197. doi: 10.1186/s12879-018-3108-7.
7
Medication-related burden and associated factors among diabetes mellitus patients at Felege Hiwot Comprehensive Specialized Hospital in northwest Ethiopia.埃塞俄比亚西北部费莱格·希沃特综合专科医院糖尿病患者的药物相关负担及相关因素
Front Clin Diabetes Healthc. 2022 Sep 9;3:977216. doi: 10.3389/fcdhc.2022.977216. eCollection 2022.
8
Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.埃塞俄比亚西北部费莱格希沃特转诊医院开始接受抗逆转录病毒治疗的HIV患者CD4细胞计数随时间变化的预测因素:多水平分析
BMC Res Notes. 2016 Jul 30;9:377. doi: 10.1186/s13104-016-2182-4.
9
Time to initial highly active antiretroviral therapy discontinuation and its predictors among HIV patients in Felege Hiwot comprehensive specialized hospital: a retrospective cohort study.在费莱盖特胡维特综合专科医院,开始停止高效抗逆转录病毒治疗的时间及其预测因素:一项回顾性队列研究。
AIDS Res Ther. 2021 Dec 4;18(1):93. doi: 10.1186/s12981-021-00418-z.
10
Predictors of non-adherence to medication and time to default from treatment on HIV infected patients under HAART: a comparison of joint and separate models.抗逆转录病毒治疗(HAART)下 HIV 感染患者药物不依从和治疗失败时间的预测因素:联合模型和单独模型的比较。
Afr Health Sci. 2022 Mar;22(1):443-455. doi: 10.4314/ahs.v22i1.53.

引用本文的文献

1
Simplified Medication Adherence Questionnaire (SMAQ) for People Living With HIV in a National Hospital in Mexico: Instrument Validation Study.墨西哥一家国立医院针对艾滋病毒感染者的简化药物依从性问卷(SMAQ):工具验证研究
Interact J Med Res. 2025 Jan 7;14:e59562. doi: 10.2196/59562.

本文引用的文献

1
Human immunodeficiency virus: The potential of medicinal plants as antiretroviral therapy.人类免疫缺陷病毒:药用植物作为抗逆转录病毒疗法的潜力。
J Med Virol. 2022 Jun;94(6):2669-2674. doi: 10.1002/jmv.27648. Epub 2022 Feb 25.
2
Moderating effects of social support on the relationship between substance use disorders and HIV viral load and medication adherence among Black women living with HIV in the United States.美国 HIV 阳性黑人女性中,社会支持对物质使用障碍与 HIV 病毒载量和药物治疗依从性之间关系的调节作用。
AIDS Care. 2022 Oct;34(10):1219-1228. doi: 10.1080/09540121.2021.2001415. Epub 2021 Nov 16.
3
Adherence and Its Associated Factors Among Adult HIV-Infected Patients on Antiretroviral Therapy in South Western Ethiopia, 2020.
2020年埃塞俄比亚西南部接受抗逆转录病毒治疗的成年HIV感染患者的治疗依从性及其相关因素
Patient Prefer Adherence. 2021 Feb 12;15:299-308. doi: 10.2147/PPA.S298594. eCollection 2021.
4
Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study.在埃塞俄比亚阿姆哈拉地区转诊医院接受一线抗逆转录病毒治疗的成年 HIV 患者中病毒学失败的发生率和预测因素:一项回顾性随访研究。
BMC Infect Dis. 2020 Jul 1;20(1):460. doi: 10.1186/s12879-020-05177-2.
5
Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.免疫恢复、失败以及与时间推移中 CD4+T 细胞进展相关的因素,在接受抗逆转录病毒疗法的埃塞俄比亚北部艾滋病毒感染者中的青少年和成年人中:一项回顾性横断面研究。
PLoS One. 2019 Dec 12;14(12):e0226293. doi: 10.1371/journal.pone.0226293. eCollection 2019.
6
HIV stigma and viral load among African-American women receiving treatment for HIV.HIV 污名与病毒载量对接受 HIV 治疗的非裔美国妇女的影响。
AIDS. 2019 Jul 15;33(9):1511-1519. doi: 10.1097/QAD.0000000000002212.
7
Clinical predictor score to identify patients at risk of poor viral load suppression at six months on antiretroviral therapy: results from a prospective cohort study in Johannesburg, South Africa.用于识别接受抗逆转录病毒治疗六个月时病毒载量抑制不佳风险患者的临床预测评分:南非约翰内斯堡一项前瞻性队列研究的结果
Clin Epidemiol. 2019 May 7;11:359-373. doi: 10.2147/CLEP.S197741. eCollection 2019.
8
A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy.在接受治疗的 HIV 患者中,病毒载量优于 CD4 细胞计数,可预测死亡率。
BMC Infect Dis. 2019 Feb 15;19(1):169. doi: 10.1186/s12879-019-3781-1.
9
Prevalence of extrapulmonary tuberculosis among people living with HIV/AIDS in sub-Saharan Africa: a systemic review and meta-analysis.撒哈拉以南非洲地区艾滋病毒/艾滋病感染者肺外结核病的患病率:一项系统评价和荟萃分析。
HIV AIDS (Auckl). 2018 Nov 5;10:225-237. doi: 10.2147/HIV.S176587. eCollection 2018.
10
Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.针对南非约翰内斯堡接受二线抗逆转录病毒治疗失败的艾滋病毒感染者的强化依从性咨询。
Trop Med Int Health. 2016 Sep;21(9):1131-7. doi: 10.1111/tmi.12741. Epub 2016 Jul 7.